Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
RNAC on Nasdaq
Christopher Jewell - trading volume in the past year for Cartesian Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
62.5K |
$202K |
$3.23 |
Jan 10, 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
67.4K |
$53.3K |
$0.79 |
Jan 10, 2025 |
Direct |
Common Stock |
|
| Employee Stock Option (right to buy) |
47.4K |
|
|
Jan 2, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.